Category: 2019, No. 10

Prevention and treatment research of fenofibrate for diabetic retinopathy and its clinical translation

Authors: Tan Guilin,  Cheng Lingyun DOI: 10.3760/cma.j.issn.2095-0160.2019.10.012 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 828-832. Abstract                               [View PDF] [Read Full Text] Diabetes is a worldwide prevalent disease and diabetic retinopathy (DR) is one of the common complications, which is vision threatening and even leading to […]

Role of adiponectin in retinopathy of prematurity

Authors: Yang Yuhang,  Zhang Guoming,  Zheng Lei DOI: 10.3760/cma.j.issn.2095-0160.2019.10.013 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 833-838. Abstract                              [View PDF] [Read Full Text] Retinopathy of prematurity (ROP) is a disease which the retinal vascular system is not mature at birth, leading to cessation of development and […]

Current surgical management approaches for uveitic glaucoma

Authors: Xiao Junyan,  Zhang Meifen DOI: 10.3760/cma.j.issn.2095-0160.2019.10.014 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 839-842. Abstract                               [View PDF] [Read Full Text] Glaucoma is a potentially blinding complication of uveitis.Management of uveitic glaucoma remains challenging.Vision can be partly recovered if correct diagnosis and timely treatment are […]

Effects of ubiqutin-proteasome system in retinopathy and their mechanism

Authors: Wang Shuai,  Liu Shengqiang DOI: 10.3760/cma.j.issn.2095-0160.2019.10.015 Published 2019-10-10 Cite as Chin J Exp Ophthalmol, 2019,37(10): 843-848. Abstract                               [View PDF] [Read Full Text] Ubiquitin-proteasome system (UPS) is the important protein degradation system in eukaryotic cells, participates in cell cycle, gene transcription, antigen-presenting, cell proliferation and differentiation, signal […]